4.6 Article

Acute Pharmacological Effects of Oral and Intranasal Mephedrone: An Observational Study in Humans

期刊

PHARMACEUTICALS
卷 14, 期 2, 页码 -

出版社

MDPI
DOI: 10.3390/ph14020100

关键词

mephedrone (4-methylmethcathinone); novel psychoactive substances (NPS); psychostimulants; cathinones bath salts; oral administration; intranasal administration

资金

  1. Instituto de Salud Carlos III (ISCIII, Fondo de Investigacion en Salud (FIS)-Fondo Europeo de Desarrollo Regional (FEDER)) [FIS PI14/00715, FIS PI17/01962]
  2. ISCIII-Red de Trastornos Adictivos RTA [RD16/0017/0003, RD16/0017/0010]
  3. AGAUR Gencat Suport Grups de Recerca [2017 SGR 316, 2017 SGR 530]
  4. Ministerio de Sanidad, Politica Social e Igualdad (Plan Nacional sobre Drogas-PNSD) [2015I054]
  5. European Commission (Predicting Risk of Emerging Drugs with In silico and Clinical Toxicology [PREDICT]) [HOME/2014/JDRU/AG/DRUG/7082]

向作者/读者索取更多资源

The study compared the acute pharmacological effects and saliva concentrations of mephedrone after oral and intranasal self-administration. Results showed that intranasal self-administration led to significantly higher concentrations, but oral route sometimes produced greater effects.
Mephedrone (4-methylmethcathinone) is a synthetic cathinone with psychostimulant properties which remains one of the most popular new psychoactive substances (NPS). It is frequently used orally and/or intranasally. To date, no studies have evaluated the acute effects and pharmacokinetics after self-administration of mephedrone orally (ingestion) and intranasally (insufflation) in naturalistic conditions. An observational study was conducted to assess and compare the acute pharmacological effects, as well as the oral fluid (saliva) concentrations of mephedrone self-administered orally and intranasally. Ten healthy experienced drug users (4 females and 6 males) self-administered a single dose of mephedrone, orally (n = 5, 100-200 mg; mean 150 mg) or intranasally (n = 5, 50-100 mg, mean 70 mg). Vital signs (blood pressure, heart rate, and cutaneous temperature) were measured at baseline (0), 1, 2, and 4 h after self-administration. Each participant completed subjective effects questionnaires: A set of Visual Analogue Scales (VAS), the 49-item Addiction Research Centre Inventory (ARCI), and Evaluation of the Subjective Effects of Substances with Abuse Potential (VESSPA-SSE) at baseline, 1, 2, and 4 h after self-administration. Oral fluid and urine were collected during 4 h. Both routes of mephedrone self-administration enhanced ratings of euphoria and well-being effects and increased cardiovascular effects in humans. Although it was at times assessed that the oral route produced greater and larger effects than the intranasal one, concentrations of mephedrone in oral fluid and also the total amount of mephedrone and metabolites in urine showed that concentrations of mephedrone are considerably higher when self-administered intranasally in comparison to orally. Controlled clinical trials are needed to confirm our observational results.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据